“Some individuals who used GLP-1 receptor agonist medications (such as semaglutide/Ozempic) subsequently reduced or abandoned efforts toward traditional diet, exercise, or lifestyle change habits”

There's real clinical concern that some GLP-1 users deprioritize diet and exercise — supported by weight regain data after stopping the drugs and a Cornell study showing grocery baskets got slightly less healthy post-medication. However, no large-scale study has directly measured how many users actually abandoned lifestyle habits, so the scale is unclear. The claim is plausible and recognized as a genuine clinical problem, but it's documented as a risk pattern rather than a proven widespread behavior. Medical consensus firmly opposes replacing lifestyle habits with medication, and some evidence suggests GLP-1s can actually improve food preferences.